How have BIOX shares performed this year?

Bioceres Crop Solutions' stock was trading at $13.73 on January 1st, 2024. Since then, BIOX stock has decreased by 19.5% and is now trading at $11.05. View the best growth stocks for 2024 here .

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) issued its earnings results on Wednesday, May, 29th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.16 by $0.02. The company earned $83.98 million during the quarter, compared to analysts' expectations of $88.80 million. Bioceres Crop Solutions had a trailing twelve-month return on equity of 0.28% and a net margin of 0.21%.

When did Bioceres Crop Solutions IPO?

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Bioceres Crop Solutions' top institutional shareholders include Oak Family Advisors LLC (0.10%) and Sumitomo Mitsui Trust Holdings Inc. (0.07%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA) , ChromaDex (CDXC) , Trevena (TRVN) , Advanced Micro Devices (AMD) , Amyris (AMRS) and Celldex Therapeutics (CLDX) .

NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

$11.05

+0.09 (+0.82%)

(As of 07/26/2024 ET)

Compare

Today's Range: $10.99
▼
$11.26
50-Day Range: $10.53
▼
$11.78
52-Week Range: $10.10
▼
$14.05

Volume: 41,878 shs
Average Volume: 58,154 shs
Market Capitalization: $693.94 million

P/E Ratio: 1,105.00
Dividend Yield: N/A
Price Target: $19.00

Get Bioceres Crop Solutions alerts:

Bioceres Crop Solutions MarketRank™ Stock Analysis

Analyst Rating: Buy
3.40 Rating Score
Upside/Downside: 71.9% Upside
$19.00 Price Target
Short Interest: Bearish
1.59% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.79
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 140.00%
From $0.35 to $0.84 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.83 out of 5 stars

Consumer Staples Sector

89th out of 136 stocks

Agricultural Chemicals Industry

5th out of 11 stocks

3.7

Analyst's Opinion

Consensus Rating
Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.40, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Bioceres Crop Solutions has only been the subject of 4 research reports in the past 90 days.
Read more about Bioceres Crop Solutions' stock forecast and price target.

2.0

Short Interest

Percentage of Shares Shorted
1.59% of the float of Bioceres Crop Solutions has been sold short.
Short Interest Ratio / Days to Cover
Bioceres Crop Solutions has a short interest ratio ("days to cover") of 9.
Change versus previous month
Short interest in Bioceres Crop Solutions has recently increased by 19.90%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Bioceres Crop Solutions does not currently pay a dividend.
Dividend Growth
Bioceres Crop Solutions does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BIOX.

3.2

News and Social Media Coverage

News Sentiment
Bioceres Crop Solutions has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Bioceres Crop Solutions this week, compared to 1 article on an average week.
Search Interest
4 people have searched for BIOX on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.
Percentage Held by Institutions
Only 17.68% of the stock of Bioceres Crop Solutions is held by institutions.
Read more about Bioceres Crop Solutions' insider trading history.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Bioceres Crop Solutions are expected to grow by 140.00% in the coming year, from $0.35 to $0.84 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bioceres Crop Solutions is 1,105.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 142.60.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bioceres Crop Solutions is 1,105.00, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.59.
Price to Book Value per Share Ratio
Bioceres Crop Solutions has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Read more about Bioceres Crop Solutions' valuation and earnings.

See Top Rated MarketRank™ Stocks Here

Ad Porter & Company

Nvidia insiders dumping shares

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

BIOX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIOX Stock News Headlines

July 20, 2024 | americanbankingnews.com

Bioceres Crop Solutions (NASDAQ:BIOX) Raised to Strong-Buy at Canaccord Genuity Group

July 19, 2024 | americanbankingnews.com

Canaccord Genuity Group Reiterates Buy Rating for Bioceres Crop Solutions (NASDAQ:BIOX)

July 27, 2024 | Stansberry Research (Ad)

Former Hedge Fund Manager Issues Crash Prediction

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

May 24, 2024 | finance.yahoo.com

Argentina's Bioceres makes world's first sales of genetically modified wheat seeds

May 15, 2024 | markets.businessinsider.com

Bioceres Crop Solutions: Robust Growth and Strategic Advancements Affirm Buy Rating

May 14, 2024 | investorplace.com

BIOX Stock Earnings: Bioceres Crop Solutions Misses EPS, Misses Revenue for Q3 2024

May 13, 2024 | businesswire.com

Bioceres Crop Solutions Reports Fiscal Third Quarter 2024 Financial and Operational Results

May 13, 2024 | msn.com

U.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed Reactions

July 27, 2024 | Stansberry Research (Ad)

Former Hedge Fund Manager Issues Crash Prediction

May 10, 2024 | businesswire.com

Bioceres Crop Solutions to Participate in the BMO Global Farm to Market Conference

May 7, 2024 | finance.yahoo.com

Bioceres Crop Solutions Announces Brazil’s Approval of New Generation Bio-Insecticide

May 7, 2024 | businesswire.com

Bioceres Crop Solutions Announces Brazil's Approval of New Generation Bio-Insecticide

May 1, 2024 | businesswire.com

Bioceres Crop Solutions to Host Fiscal Third Quarter 2024 Financial Results Conference Call on Tuesday, May 14, 2024 at 8:30 a.m. Eastern Time

April 11, 2024 | markets.businessinsider.com

Pro Farm(TM) Group Inc and Ingenium(R) Group LLC Announce Zero Waste Achievement

March 23, 2024 | seekingalpha.com

Bioceres Needs To Add Clarity Around Borrowings

March 6, 2024 | businesswire.com

Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference

March 6, 2024 | businesswire.com

Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference

March 5, 2024 | investorplace.com

Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio

See More Headlines

Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/29/2024
Today: 7/26/2024
Next Earnings (Estimated): 9/09/2024
Fiscal Year End: 6/30/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Consumer Staples
Industry: Agricultural chemicals
Sub-Industry: N/A
Current Symbol: NASDAQ:BIOX
CUSIP: N/A
CIK: 1769484
Web: biocerescrops.com
Phone: 543414861100
Fax: N/A
Employees: 447
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $19.00
High Stock Price Target: $25.00
Low Stock Price Target: $15.00
Potential Upside/Downside: +71.3%
Consensus Rating: Buy
Rating Score (0-4): 3.40
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.01
Trailing P/E Ratio: 1,109.00
Forward P/E Ratio: 31.69
P/E Growth: N/A
Net Income: $18.78 million
Net Margins: 0.21%
Pretax Margin: 2.64%
Return on Equity: 0.28%
Return on Assets: 0.12%

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 1.22
Quick Ratio: 0.83

Sales & Book Value

Annual Sales: $419.80 million
Price / Sales: 1.66
Cash Flow: $0.58 per share
Price / Cash Flow: 19.16
Book Value: $5.26 per share
Price / Book: 2.11

Miscellaneous

Outstanding Shares: 62,800,000
Free Float: 61,346,000
Market Cap: $696.45 million
Optionable: Optionable
Beta: 0.50

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Jose A. Roque
General Counsel
Alex Garcia
Managing Director of Seeds
Dr. Federico Trucco Ph.D. (Age 47)
Executive Chairman & CEO
Comp: $131.16k
Mr. Enrique López Lecube (Age 42)
CFO & Executive Director
Comp: $129.89k
Mr. Jorge Wagner (Age 55)
Chief Operating Officer
Comp: $165.6k
Ms. Paula Savanti
Head of Investor Relations
Ms. Gloria Montaron Estrada (Age 53)
Executive Director
Mr. Ricardo Luis Yapur (Age 65)
Managing Director of Latam Unit & Chief Commercial Officer
Comp: $260k
Mr. Matti Tiainen (Age 34)
Managing Director of North America & Europe

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BIOX Stock Analysis - Frequently Asked Questions

How have BIOX shares performed this year?: Bioceres Crop Solutions' stock was trading at $13.73 on January 1st, 2024. Since then, BIOX stock has decreased by 19.5% and is now trading at $11.05.
View the best growth stocks for 2024 here.
How were Bioceres Crop Solutions' earnings last quarter?: Bioceres Crop Solutions Corp. (NASDAQ:BIOX) issued its earnings results on Wednesday, May, 29th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.16 by $0.02. The company earned $83.98 million during the quarter, compared to analysts' expectations of $88.80 million. Bioceres Crop Solutions had a trailing twelve-month return on equity of 0.28% and a net margin of 0.21%.
When did Bioceres Crop Solutions IPO?: Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering on Wednesday, February 7th 2018. The company issued 11,800,000 shares at a price of $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.
Who are Bioceres Crop Solutions' major shareholders?: Bioceres Crop Solutions' top institutional shareholders include Oak Family Advisors LLC (0.10%) and Sumitomo Mitsui Trust Holdings Inc. (0.07%).
How do I buy shares of Bioceres Crop Solutions?: Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
What other stocks do shareholders of Bioceres Crop Solutions own?: Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include Arcadia Biosciences (RKDA), ChromaDex (CDXC), Trevena (TRVN), Advanced Micro Devices (AMD), Amyris (AMRS) and Celldex Therapeutics (CLDX).